Unity Biotechnology
| Industry | Biotechnology, Pharmaceutical |
|---|---|
| Founded | 2011 in California, United States of America |
| Founders | Jan van Deursen, Nathaniel “Ned” David |
| Headquarters | |
| Website | unitybiotechnology |
Unity Biotechnology is a startup biotechnology company that aims to develop drugs which target senescent cells with the aim of extending life span.[1][2][3][4][5][6][7]
See also
References
- ^ Brueck, Hilary (3 February 2016). "Mayo Clinic Taps Silicon Valley to Help People Age Gracefully". Fortune (magazine). Retrieved 19 February 2018.
- ^ Detrixhe, John (21 February 2018). "Crypto millionaires are funding research to reverse the aging process". Quartz (publication). Retrieved 19 February 2018.
- ^ Herkewitz, William (19 February 2018). "Scientists Can Now Radically Expand the Lifespan of Mice—and Humans May Be Next". Popular Mechanics. Retrieved 19 February 2018.
- ^ Ramsey, Lydia (10 November 2018). "A biotech startup that aims to rid our bodies of cells related to aging just got a big investment". Business Insider. Retrieved 10 November 2018.
- ^ Scudellari, Megan (25 February 2017). "To Stay Young, Kill Zombie Cells". Scientific America. Retrieved 19 February 2018.
- ^ Greenfieldboyce, Nell (3 February 2016). "Boosting Life Span By Clearing Out Cellular Clutter". Retrieved 19 February 2018.
- ^ Baker, Darren (11 February 2016). "Naturally occurring p16Ink4a-positive cells shorten healthy lifespan". Nature (journal). doi:10.1038/nature16932. Retrieved 19 February 2018.
External links
 | This corporation or company article is a stub. You can help Wikipedia by expanding it. |